Nuveen completed its acquisition of Schroders on 1 October 2026, bringing businesses with $2.6 trillion in assets under management, measured at 30 June, under common ownership. Its completion announcement keeps Schroders operating separately for 12–18 months while integration is planned.[1]
The legal buyer is Pantheon, LLC, Nuveen’s wholly owned acquisition subsidiary within TIAA. Delivery of the court order to the Registrar of Companies made the scheme effective on 1 October, transferring all issued and to-be-issued Schroders share capital to the buyer.[2]
The next step is also complete: Schroders’ 2 October regulatory announcement confirms that its FCA listing and London Stock Exchange main-market trading were cancelled at 08:00 London time that day. The company has left the public market even though operational integration continues.[3]
Shareholder consideration has its own timetable
Holders on the register at 18:00 London time on 30 September became entitled to 590p cash per scheme share. The effective-scheme announcement set 15 October as the latest settlement date. That is the published payment obligation; it does not establish when every nominee or individual shareholder account was credited.[2]
The original offer’s figure of up to 612p combined the 590p cash consideration with up to 22p of permitted dividends. On that full-dividend basis, the announced fully diluted equity value was approximately £9.9 billion. The two per-share figures answer different questions: takeover cash and total value including eligible dividends.[4]
For illustration, 1,000 scheme shares carry £5,900 of takeover cash. The original dividend allowance could add up to £220, subject to the relevant declaration and entitlement. Against the 456p closing price on 11 February, the cash-only premium calculates to 29.4%; including the maximum dividends produces 34.2%. These are offer-price comparisons, not returns earned by every holder.[4]
Financing terms add a cost to the scale
Ahead of completion, Nuveen priced sterling and dollar senior notes on 22 September. The stated possible uses included acquisition consideration and transaction costs alongside general corporate purposes.[6]
Senior notes priced before completion
| Principal | Coupon | Maturity |
|---|---|---|
| £550 million | 6.052% | 25 September 2031Source 6 |
| $750 million | 5.572% | 25 September 2029Source 6 |
| $750 million | 5.738% | 25 September 2031Source 6 |
| $500 million | 6.063% | 25 September 2036Source 6 |
At the disclosed full principal amounts, annual coupons calculate to £33.286 million on the sterling tranche and $115.14 million across the dollar tranches. These are separate-currency coupon amounts, excluding fees, hedging and other financing. They show a recurring funding cost; they are not the acquisition’s complete financing bill.[6]
The business case is access to clients as well as assets
The scheme document identifies a complementary distribution route: Nuveen gives Schroders access to US wealth and institutional channels, while Schroders brings Nuveen access to clients in Europe, the Middle East, Africa and Asia-Pacific. This matters economically because an existing sales relationship can introduce more investment capabilities without acquiring the customer relationship again. It still requires suitable products, client approval and retention; common ownership alone does not create net inflows.[5]
Nuveen’s completion release says the firms intend to preserve existing investment teams for at least 12–18 months and eventually build a unified investment platform. Its $400 billion private-markets platform is intended to be organised by asset class. The plan combines continuity for current mandates with a broader future offering.[1]
The March scheme also set London as the combined group’s non-US headquarters for at least five years and retained Schroders’ wealth business, including Cazenove Capital. Those choices make the integration more than an exercise in removing a listing: the buyer is preserving distribution and specialist relationships it expects to use. The next commercial evidence will be client retention, new mandates and operating results as those capabilities are brought together.[5]
Sources & further reading
- Acquisition completion Nuveen via PRNewswire · 1 Oct 2026 · Accessed 21 Oct 2026
- Scheme effective Schroders via RNS/Investegate · 1 Oct 2026 · Accessed 21 Oct 2026
- Delisting confirmation Schroders via RNS/London South East · 2 Oct 2026 · Accessed 21 Oct 2026
- Cash offer terms Nuveen and Schroders · 12 Feb 2026 · Accessed 21 Oct 2026
- Scheme document Schroders · 12 Mar 2026 · Accessed 21 Oct 2026
- Senior notes pricing Nuveen via PRNewswire · 22 Sep 2026 · Accessed 21 Oct 2026